Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS)
- PMID: 3298431
Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS)
Abstract
The antigen specificity of two immunoprotective monoclonal antibodies derived from mice immunized with Escherichia coli 0111:B4 bacteria and boosted with purified lipopolysaccharide (LPS) were investigated. One of the antibodies, B7, was shown by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunostaining to bind to the O-antigen containing LPS species, whereas the other antibody, 5B10, reacted with both O-antigen containing homologs and the O-antigen-deficient LPS. 5B10 did not bind to LPS from E. coli J5, an Rc mutant of E. coli 0111:B4 that lacks both the O-antigen and outer core sugars. 5B10 did not cross-react with LPS from several other E. coli strains. Thus 5B10 appeared to recognize a type-specific epitope in the outer core of LPS exclusive of Rc determinants. The monoclonal antibody specific for the polymeric O-antigen is of the IgG3 subclass, and the monoclonal antibody 5B10 specific for the outer core of LPS is an IgG2a. Although B7 and 5B10 were equally able to protect mice from a lethal challenge of E. coli 0111:B4 organisms, the outer core-specific IgG2a antibody was much more efficient at mediating the binding of human complement C3 than the O-antigen-specific IgG3 monoclonal antibody.
Similar articles
-
Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.Surgery. 1985 Aug;98(2):283-90. Surgery. 1985. PMID: 3895540
-
Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.J Surg Res. 1997 May;69(2):249-54. doi: 10.1006/jsre.1997.5013. J Surg Res. 1997. PMID: 9224390
-
Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.J Immunol. 1984 Aug;133(2):950-7. J Immunol. 1984. PMID: 6203984
-
Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.Int J Med Microbiol. 2007 Sep;297(5):321-40. doi: 10.1016/j.ijmm.2007.04.002. Epub 2007 Jun 1. Int J Med Microbiol. 2007. PMID: 17544324 Review.
-
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.Pediatr Res. 1976 Feb;10(2):82-7. doi: 10.1203/00006450-197602000-00002. Pediatr Res. 1976. PMID: 1107953 Review.
Cited by
-
Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.Infect Immun. 1992 Jun;60(6):2506-13. doi: 10.1128/iai.60.6.2506-2513.1992. Infect Immun. 1992. PMID: 1587618 Free PMC article.
-
A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.Infect Immun. 1991 Jan;59(1):1-6. doi: 10.1128/iai.59.1.1-6.1991. Infect Immun. 1991. PMID: 1898896 Free PMC article.
-
Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111.Appl Environ Microbiol. 2000 Sep;66(9):4124-7. doi: 10.1128/AEM.66.9.4124-4127.2000. Appl Environ Microbiol. 2000. PMID: 10966439 Free PMC article.
-
Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.Infection. 1991 Nov-Dec;19(6):383-90. doi: 10.1007/BF01726444. Infection. 1991. PMID: 1816107 Review. No abstract available.
-
Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.Clin Vaccine Immunol. 2008 Apr;15(4):590-7. doi: 10.1128/CVI.00476-07. Epub 2008 Feb 13. Clin Vaccine Immunol. 2008. PMID: 18272666 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous